Advertisement

Topics

Samsung Bioepis Co., Ltd. Company Profile

01:46 EDT 17th October 2017 | BioPortfolio

Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to increasing patient access to affordable, high-quality biologic medicines. Through innovations in product development and quality assurance, Samsung Bioepis aims to become the world's leading biopharmaceutical company. Samsung Bioepis is a joint venture between Samsung BioLogics and Biogen. For more information, please visit: www.samsungbioepis.com.


News Articles [241 Associated News Articles listed on BioPortfolio]

Samsung Bioepis Forms Novel Biologics JV with Takeda Pharma

Samsung Bioepis, a division of Samsung Biologics, announced a joint venture with Japan's Takeda Pharma to develop novel biologic drugs. The JV's first project will be TAK-671, a candidate aimed at sev...

Samsung Bioepis signs R&D agreement with Takeda

Samsung Bioepis is to broaden its research into novel pharmaceuticals with a new R&D agreement with Takeda. Samsung Bioepis is a joint venture between South Korea’s Samsung and Biogen, and has ...

Samsung Bioepis and Takeda in Biologics Pact

South Korean biopharmaceutical company Samsung Bioepis is taking its first step into novel drug development with an agreement to partner Japan’s Takeda Pharmaceutical. The move expands Samsung B...

Samsung Bioepis, Takeda collaborate on severe pancreatitis therapy

Samsung Bioepis has joined with Takeda to develop multiple novel biologic therapies, including the collaboration’s first therapeutic candidate, TAK-671 for severe acute pancreatitis, according to a ...

Samsung Bioepis Gets European Approval for Biosimilar of Best-Selling Antibody

Samsung Bioepis has announced the European Commission approved Imraldi, a biosimilar of AbbVie’s Humira (adalimumab), which has topped revenue charts for years. Samsung Bioepis’ Imraldi ha...

Samsung Bioepis eyes branded biologics

Biosimilar-drug maker Samsung Bioepis is working with Takeda to develop new biologic drugs, including one for acute pancreati -More- 

Samsung Bioepis and Takeda enter biologics co-development deal

Samsung Bioepis Co. Ltd., a joint venture formed by Samsung BioLogics and Biogen Inc., and Takeda Pharmaceutical Co. Ltd. entered an agreement to co-fund and co-develop biologics for diseases of unmet...

EMA committee gives Samsung Bioepis nod for Humira biosimilar Imraldi

The EMA has recommended the approval of Samsung Bioepis’ adalimumab biosimilar, placing the firm on the brink of having three anti-TNF inhibitors in Europe.

Drugs and Medications [0 Results]

None

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Benchmarking desktop and mobile handwriting across COTS devices: The e-BioSign biometric database.

This paper describes the design, acquisition process and baseline evaluation of the new e-BioSign database, which includes dynamic signature and handwriting information. Data is acquired from 5 differ...

Association Between Coronary Artery Calcification and the Hemoglobin Glycation Index: The Kangbuk Samsung Health Study.

The hemoglobin glycation index (HGI) is known to be correlated with the risk of cardiovascular disease.

Examining Authenticity: An Initial Exploration of the Suitability of Handwritten Electronic Signatures.

Considering the increasing relevance of handwritten electronically captured signatures, we evaluated the ability of forensic handwriting examiners (FHEs) to distinguish between authentic and simulated...

Glaucomatous Optic Nerve Changes and Thyroid Dysfunction in an Urban South Korean Population.

Purpose. This study was performed to evaluate the relationship between intraocular pressure (IOP) and glaucomatous optic nerve change and thyroid factors in Korean population. Materials and Methods. T...

Natural course of untreated cluster headache: A retrospective cohort study.

Objective To determine the natural course of cluster headache. Methods We screened patients with cluster headache who were diagnosed at Samsung Medical Center and lost to follow-up for ≥5 years. Eli...

Clinical Trials [17 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Samsung LABGEO IVD-A20 CHF Test in a Point-of-Care Setting

To establish the performance characteristics of the Samsung LABGEO IVD-A20 CHF Test in intended use settings, by comparing test results of the A20 CHF Test with results obtained from an FD...

Gait Pattern Analysis and Feasibility of Gait Training With a Walking Assist Robot in Stroke Patients and Elderly Adults

The purpose of this study was to investigate the effects of the new wearable hip assist robot developed by Samsung Advanced Institute of Technology (Samsung Electronics Co, Ltd., Korea) to...

Analysis of Sweat Secretions and Body Dehydration Monitor

Monitoring of a person's physical status is a key point for maintaining of "healthy life". Wearable devices provide a unique possibility for real-time monitoring. This study aims to estima...

Development and Validation of a Novel Stereoacuity Test Using Head-mounted Display

This prospective study investigated the validity and test-retest reliability of stereopsis test using head-mount display (HMD). Contour-based circles (crossed disparity: 1,960 to 195 arc o...

The Effect of a Walking Assist Robot on Gait Function and Brain Activity in Stroke Patients and Elderly Adults

The purpose of this study was to investigate the effects of the new wearable hip assist robot, gait enhancing mechatronic system (GEMS) developed by Samsung Advanced Institute of Technolog...

Companies [22 Associated Companies listed on BioPortfolio]

Samsung Bioepis Co., Ltd.

Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to increasing patient access to affordable, high-quality biologic medicines. Through innovations in p...

Samsung Electronics America

Samsung Electronics America, Inc. (SEA), based in Ridgefield Park, NJ, is a subsidiary of Samsung Electronics Co., Ltd. The company markets a broad range of award-winning consumer...

Samsung Electronics North America

Samsung Electronics North America (NAHQ), based in Ridgefield Park, NJ, is an arm of Samsung Electronics Co., Ltd. The company markets a broad range of award-winning consumer elec...

Samsung Electronics America, Inc.

Samsung Electronics America, Inc. (SEA), based in Ridgefield Park, NJ, is a subsidiary of Samsung Electronics Co., Ltd. The company markets a broad range of award-winning consumer...

Samsung Electronics America Inc.

As a global leader in Information Technology, Samsung’s Enterprise Business Division (EBD) is committed to introducing new business experiences across a diverse spectrum of i...

More Information about "Samsung Bioepis Co., Ltd." on BioPortfolio

We have published hundreds of Samsung Bioepis Co., Ltd. news stories on BioPortfolio along with dozens of Samsung Bioepis Co., Ltd. Clinical Trials and PubMed Articles about Samsung Bioepis Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Samsung Bioepis Co., Ltd. Companies in our database. You can also find out about relevant Samsung Bioepis Co., Ltd. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record